Advanced

Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies

Hansson, Jenny; Galanti, Maria Rosaria; Hergens, Maria-Pia; Fredlund, Peeter; Ahlbom, Anders; Alfredsson, Lars; Bellocco, Rino; Eriksson, Marie; Hallqvist, Johan and Hedblad, Bo LU , et al. (2012) In European Journal of Epidemiology 27(10). p.771-779
Abstract
The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is common in Sweden and increasing elsewhere, is receiving increasing attention since considered a tobacco smoke "potential reduction exposure product". Snus delivers a high dose of nicotine with possible hemodynamic effects, but its impact on cardiovascular morbidity and mortality is uncertain. The aim of this study was to investigate whether snus use is associated with risk of and survival after acute myocardial infarction (AMI). Data from eight prospective cohort studies set in Sweden was pooled and reanalysed. The relative risk of first time AMI and 28-day case-fatality was calculated for 130,361 men who never smoked. During 2,262,333... (More)
The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is common in Sweden and increasing elsewhere, is receiving increasing attention since considered a tobacco smoke "potential reduction exposure product". Snus delivers a high dose of nicotine with possible hemodynamic effects, but its impact on cardiovascular morbidity and mortality is uncertain. The aim of this study was to investigate whether snus use is associated with risk of and survival after acute myocardial infarction (AMI). Data from eight prospective cohort studies set in Sweden was pooled and reanalysed. The relative risk of first time AMI and 28-day case-fatality was calculated for 130,361 men who never smoked. During 2,262,333 person-years of follow-up, 3,390 incident events of AMI were identified. Current snus use was not associated with risk of AMI (pooled multivariable hazard ratio 1.04, 95 % confidence interval 0.93 to 1.17). The short-term case fatality rate appeared increased in snus users (odds ratio 1.28, 95 % confidence interval 0.99 to 1.68). This study does not support any association between use of snus and development of AMI. Hence, toxic components other than nicotine appear implicated in the pathophysiology of smoking related ischemic heart disease. Case fatality after AMI is seemingly increased among snus users, but this relationship may be due to confounding by socioeconomic or life style factors. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Acute myocardial infarction, Smokeless tobacco, Snus, The Swedish, collaboration on health effects of snus use
in
European Journal of Epidemiology
volume
27
issue
10
pages
771 - 779
publisher
Springer
external identifiers
  • wos:000310891300002
  • scopus:84871293459
ISSN
1573-7284
DOI
10.1007/s10654-012-9704-8
language
English
LU publication?
yes
id
fd75d961-d926-461b-b04a-396aac5961f2 (old id 3388508)
date added to LUP
2013-02-01 07:04:20
date last changed
2017-11-19 03:07:19
@article{fd75d961-d926-461b-b04a-396aac5961f2,
  abstract     = {The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is common in Sweden and increasing elsewhere, is receiving increasing attention since considered a tobacco smoke "potential reduction exposure product". Snus delivers a high dose of nicotine with possible hemodynamic effects, but its impact on cardiovascular morbidity and mortality is uncertain. The aim of this study was to investigate whether snus use is associated with risk of and survival after acute myocardial infarction (AMI). Data from eight prospective cohort studies set in Sweden was pooled and reanalysed. The relative risk of first time AMI and 28-day case-fatality was calculated for 130,361 men who never smoked. During 2,262,333 person-years of follow-up, 3,390 incident events of AMI were identified. Current snus use was not associated with risk of AMI (pooled multivariable hazard ratio 1.04, 95 % confidence interval 0.93 to 1.17). The short-term case fatality rate appeared increased in snus users (odds ratio 1.28, 95 % confidence interval 0.99 to 1.68). This study does not support any association between use of snus and development of AMI. Hence, toxic components other than nicotine appear implicated in the pathophysiology of smoking related ischemic heart disease. Case fatality after AMI is seemingly increased among snus users, but this relationship may be due to confounding by socioeconomic or life style factors.},
  author       = {Hansson, Jenny and Galanti, Maria Rosaria and Hergens, Maria-Pia and Fredlund, Peeter and Ahlbom, Anders and Alfredsson, Lars and Bellocco, Rino and Eriksson, Marie and Hallqvist, Johan and Hedblad, Bo and Jansson, Jan-Hakan and Nilsson, Peter and Pedersen, Nancy and Lagerros, Ylva Trolle and Ostergren, Per-Olof and Magnusson, Cecilia},
  issn         = {1573-7284},
  keyword      = {Acute myocardial infarction,Smokeless tobacco,Snus,The Swedish,collaboration on health effects of snus use},
  language     = {eng},
  number       = {10},
  pages        = {771--779},
  publisher    = {Springer},
  series       = {European Journal of Epidemiology},
  title        = {Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies},
  url          = {http://dx.doi.org/10.1007/s10654-012-9704-8},
  volume       = {27},
  year         = {2012},
}